Literature DB >> 22366569

Selected echocardiographic variables change more rapidly in dogs that die from myxomatous mitral valve disease.

Melanie J Hezzell1, Adrian Boswood, Walasinee Moonarmart, Jonathan Elliott.   

Abstract

OBJECTIVES: To determine if echocardiographic measurements change at a greater rate in dogs with myxomatous mitral valve disease (MMVD) that die of cardiac mortality. ANIMALS: Client-owned dogs (n = 242) with MMVD of varying severity were recruited from first opinion private practice. Only dogs which died during the study period (n = 102) were included in statistical analyses.
METHODS: Prospective cohort study comparing the rate of change of echocardiographic variables between dogs that experienced cardiac mortality and those that experienced non-cardiac mortality. Measurements were repeated approximately every 6 months and repeated measures linear models were constructed to estimate the rate of change of each variable over time.
RESULTS: Left ventricular (LV) end-diastolic diameter, normalized for body weight (LVEDDN) increased over time in both mortality groups. LV end-systolic diameter, normalized for body weight (LVESDN), LV end-diastolic diameter to LV free wall thickness in diastole (LVEDD/LVFWd) ratio, E wave velocity, E- to A-wave velocity ratio and left atrial to aortic root diameter ratio all increased over time in the cardiac mortality group, but did not change in the non-cardiac mortality group. MR velocity decreased over time in the cardiac mortality group but did not change in the non-cardiac mortality group. Tricuspid regurgitation jet velocity increased over time in both mortality groups. A wave velocity and fractional shortening did not change over time in either mortality group.
CONCLUSIONS: Serial echocardiographic examination every 6-12 months is useful to identify dogs with progressive MMVD that are at increased risk of cardiac mortality. Copyright Â
© 2012 Elsevier B.V. All rights reserved.

Entities:  

Mesh:

Year:  2012        PMID: 22366569     DOI: 10.1016/j.jvc.2012.01.009

Source DB:  PubMed          Journal:  J Vet Cardiol        ISSN: 1760-2734            Impact factor:   1.701


  17 in total

1.  The Mitral INsufficiency Echocardiographic score: A severity classification of myxomatous mitral valve disease in dogs.

Authors:  Tommaso Vezzosi; Giovanni Grosso; Rosalba Tognetti; Valentina Meucci; Valentina Patata; Federica Marchesotti; Oriol Domenech
Journal:  J Vet Intern Med       Date:  2021-05-05       Impact factor: 3.333

2.  Red Blood Cell Distribution Width, Hematology, and Serum Biochemistry in Dogs with Echocardiographically Estimated Precapillary and Postcapillary Pulmonary Arterial Hypertension.

Authors:  E Mazzotta; C Guglielmini; G Menciotti; B Contiero; M Baron Toaldo; M Berlanda; H Poser
Journal:  J Vet Intern Med       Date:  2016-10-17       Impact factor: 3.333

3.  Echocardiographic Estimates of Right Ventricular Systolic Function in Dogs with Myxomatous Mitral Valve Disease.

Authors:  E H Chapel; B A Scansen; K E Schober; J D Bonagura
Journal:  J Vet Intern Med       Date:  2017-12-10       Impact factor: 3.333

4.  Prognostic value of echocardiographic indices of left atrial morphology and function in dogs with myxomatous mitral valve disease.

Authors:  Marco Baron Toaldo; Giovanni Romito; Carlo Guglielmini; Alessia Diana; Nazzareno G Pelle; Barbara Contiero; Mario Cipone
Journal:  J Vet Intern Med       Date:  2018-03-23       Impact factor: 3.333

5.  ACVIM consensus guidelines for the diagnosis and treatment of myxomatous mitral valve disease in dogs.

Authors:  Bruce W Keene; Clarke E Atkins; John D Bonagura; Philip R Fox; Jens Häggström; Virginia Luis Fuentes; Mark A Oyama; John E Rush; Rebecca Stepien; Masami Uechi
Journal:  J Vet Intern Med       Date:  2019-04-11       Impact factor: 3.333

6.  Echocardiographic quantitation of left heart size and function in 122 healthy dogs: A prospective study proposing reference intervals and assessing repeatability.

Authors:  Lance C Visser; Marisa M Ciccozzi; Daniel J Sintov; Ashley N Sharpe
Journal:  J Vet Intern Med       Date:  2019-07-16       Impact factor: 3.333

7.  Effect of temperature variation on hospital admissions and outcomes in dogs with myxomatous mitral valve disease and new onset pulmonary edema.

Authors:  Carlo Guglielmini; Marco Baron Toaldo; Alex Chiesa; Barbara Contiero; Michele Berlanda; Helen Poser
Journal:  PLoS One       Date:  2020-01-14       Impact factor: 3.240

8.  Longitudinal Analysis of Quality of Life, Clinical, Radiographic, Echocardiographic, and Laboratory Variables in Dogs with Preclinical Myxomatous Mitral Valve Disease Receiving Pimobendan or Placebo: The EPIC Study.

Authors:  A Boswood; S G Gordon; J Häggström; G Wess; R L Stepien; M A Oyama; B W Keene; J Bonagura; K A MacDonald; M Patteson; S Smith; P R Fox; K Sanderson; R Woolley; V Szatmári; P Menaut; W M Church; M L O'Sullivan; J-P Jaudon; J-G Kresken; J Rush; K A Barrett; S L Rosenthal; A B Saunders; I Ljungvall; M Deinert; E Bomassi; A H Estrada; M J Fernandez Del Palacio; N S Moise; J A Abbott; Y Fujii; A Spier; M W Luethy; R A Santilli; M Uechi; A Tidholm; C Schummer; P Watson
Journal:  J Vet Intern Med       Date:  2017-12-06       Impact factor: 3.333

9.  Mitral Regurgitation Severity and Left Ventricular Systolic Dimension Predict Survival in Young Cavalier King Charles Spaniels.

Authors:  M J Reimann; J E Møller; J Häggström; T Martinussen; S S C Zatrazemi; L Svanholm; L B M Nielsen; H D Pedersen; L H Olsen
Journal:  J Vet Intern Med       Date:  2017-06-01       Impact factor: 3.333

10.  Temporal changes in clinical and radiographic variables in dogs with preclinical myxomatous mitral valve disease: The EPIC study.

Authors:  Adrian Boswood; Sonya G Gordon; Jens Häggström; Martin Vanselow; Gerhard Wess; Rebecca L Stepien; Mark A Oyama; Bruce W Keene; John Bonagura; Kristin A MacDonald; Mark Patteson; Sarah Smith; Philip R Fox; Karen Sanderson; Richard Woolley; Viktor Szatmári; Pierre Menaut; Whitney M Church; M Lynne O'Sullivan; Jean-Philippe Jaudon; Jan-Gerd Kresken; John Rush; Kirstie A Barrett; Steven L Rosenthal; Ashley B Saunders; Ingrid Ljungvall; Michael Deinert; Eric Bomassi; Amara H Estrada; Maria J Fernandez Del Palacio; N Sydney Moise; Jonathan A Abbott; Yoko Fujii; Alan Spier; Michael W Luethy; Roberto A Santilli; Masami Uechi; Anna Tidholm; Christoph Schummer; Philip Watson
Journal:  J Vet Intern Med       Date:  2020-03-22       Impact factor: 3.333

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.